Abstract
Medication adherence in heart failure is especially complex due to the nature of the syndrome. Heart failure develops secondary to a wide variety of etiologies and covers a broad spectrum of symptom severity. Heart failure is commonly accompanied by coronary artery disease, hypertension, dyslipidemia, atrial fibrillation, and diabetes mellitus. As a result, patients with heart failure take medications not only for heart failure, but also for a number of other medical conditions. Hence, polypharmacy is common in heart failure patients. Reported medication adherence rates in patients with heart failure have ranged from 2% to 90% reflecting the broad range of types of patients who have heart failure and the differing methods used to assess adherence. A number of barriers to good adherence have been identified in patients with heart failure. Strategies to overcome these barriers have been described, but are often focused on single aspects of improving adherence, which tend to produce relatively small improvements in overall medication adherence. The most productive strategies to improve adherence typically involve multifactorial, multidisciplinary interventions. Disease management programs for heart failure, although not specifically designed to focus only on medication adherence, have been shown to improve adherence to a number of treatments including medications, diet, and exercise. Disease management programs have also been shown to favorably impact the frequency of heart failure hospitalizations and mortality in selected populations of heart failure patients. Efforts continue to define the most appropriate strategies to produce improvements in medication adherence in patients with heart failure.
| Original language | English |
|---|---|
| Title of host publication | The Kidney in Heart Failure |
| Publisher | Springer US |
| Pages | 183-202 |
| Number of pages | 20 |
| Volume | 9781461436942 |
| ISBN (Electronic) | 9781461436942 |
| ISBN (Print) | 1461436931, 9781461436935 |
| DOIs | |
| State | Published - Nov 1 2012 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
Medication adherence in heart failure. / Hilleman, Daniel E.; Campbell, Jennifer A.
The Kidney in Heart Failure. Vol. 9781461436942 Springer US, 2012. p. 183-202.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Medication adherence in heart failure
AU - Hilleman, Daniel E.
AU - Campbell, Jennifer A.
PY - 2012/11/1
Y1 - 2012/11/1
N2 - Medication adherence in heart failure is especially complex due to the nature of the syndrome. Heart failure develops secondary to a wide variety of etiologies and covers a broad spectrum of symptom severity. Heart failure is commonly accompanied by coronary artery disease, hypertension, dyslipidemia, atrial fibrillation, and diabetes mellitus. As a result, patients with heart failure take medications not only for heart failure, but also for a number of other medical conditions. Hence, polypharmacy is common in heart failure patients. Reported medication adherence rates in patients with heart failure have ranged from 2% to 90% reflecting the broad range of types of patients who have heart failure and the differing methods used to assess adherence. A number of barriers to good adherence have been identified in patients with heart failure. Strategies to overcome these barriers have been described, but are often focused on single aspects of improving adherence, which tend to produce relatively small improvements in overall medication adherence. The most productive strategies to improve adherence typically involve multifactorial, multidisciplinary interventions. Disease management programs for heart failure, although not specifically designed to focus only on medication adherence, have been shown to improve adherence to a number of treatments including medications, diet, and exercise. Disease management programs have also been shown to favorably impact the frequency of heart failure hospitalizations and mortality in selected populations of heart failure patients. Efforts continue to define the most appropriate strategies to produce improvements in medication adherence in patients with heart failure.
AB - Medication adherence in heart failure is especially complex due to the nature of the syndrome. Heart failure develops secondary to a wide variety of etiologies and covers a broad spectrum of symptom severity. Heart failure is commonly accompanied by coronary artery disease, hypertension, dyslipidemia, atrial fibrillation, and diabetes mellitus. As a result, patients with heart failure take medications not only for heart failure, but also for a number of other medical conditions. Hence, polypharmacy is common in heart failure patients. Reported medication adherence rates in patients with heart failure have ranged from 2% to 90% reflecting the broad range of types of patients who have heart failure and the differing methods used to assess adherence. A number of barriers to good adherence have been identified in patients with heart failure. Strategies to overcome these barriers have been described, but are often focused on single aspects of improving adherence, which tend to produce relatively small improvements in overall medication adherence. The most productive strategies to improve adherence typically involve multifactorial, multidisciplinary interventions. Disease management programs for heart failure, although not specifically designed to focus only on medication adherence, have been shown to improve adherence to a number of treatments including medications, diet, and exercise. Disease management programs have also been shown to favorably impact the frequency of heart failure hospitalizations and mortality in selected populations of heart failure patients. Efforts continue to define the most appropriate strategies to produce improvements in medication adherence in patients with heart failure.
UR - http://www.scopus.com/inward/record.url?scp=84949175578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949175578&partnerID=8YFLogxK
U2 - 10.1007/978-1-4614-3694-2_13
DO - 10.1007/978-1-4614-3694-2_13
M3 - Chapter
SN - 1461436931
SN - 9781461436935
VL - 9781461436942
SP - 183
EP - 202
BT - The Kidney in Heart Failure
PB - Springer US
ER -